1 / 10

Chronic Lower Back Pain Market

Chronic Lower Back Pain persists for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain has been treated. Low back pain is very common and at one point everyone may have faced this problem.<br>

DelveInsight
Download Presentation

Chronic Lower Back Pain Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chronic Lower Back Pain Chronic Lower Back Pain persists for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain has been treated. Low back pain is very common and at one point everyone may have faced this problem. The exact cause of lower back pain is unknown. Lower back pain that is long-term is called chronic low back pain, this condition might originate from an injury, disease, or stress on different structures of the body, and pain may vary significantly. • 1 • 2 • 3 • 4 Pain severity may form bi-dimensional or one-dimensional scale depending on the specific instruments tested. High inter-correlations between pain-intensity measures and pain-related disability measures support a unitary construct of pain severity. Various scales are used by experts in order to assess the severity of pain in CLBP patients, two of the most widely used are Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS). • DelveInsight © 2019 | All rights reserved

  2. CLBP Epidemiology Chronic Lower Back Paintotalprevalent population was observed to be 73,802,461 in 2017 in the 7MM that is expected to increase during the study period i.e. 2017-2028. The total CBLP diagnosed prevalent population in the 7MM was assessed to be 44,281,476 in 2017. CLBP prevalence Chronic Lower Back Pain CLBP PREVALENCE The highest CBLP diagnosed prevalence was more than 20 million cases in 2017in the United States. CLBP prevalence A higher percentage of CBLP diagnosed prevalence was observed for females as compared to males in all the 7MM countries, except Japan, wherein males occupy a larger patient pool than females. CLBP OCCURENCE • DelveInsight © 2019 | All rights reserved

  3. CLBP Market Chronic Lower Back Painmarket size in the 7MM is expected to grow at a CAGR of 4.84% for the study period (2017- 2028). CLBP is mostly diagnosed in the age group of 40-69. Moreover, it has been observed that moderate to severe are the majorly diagnosed CLBP patients. With the launch of the effective therapies, CBLP market is going to rise that will introduce USD 623.19 million in 2022 to the overall CBLP therapies market. CLBP current pharmacological treatments do not meet the needs of all patients. NSAIDs, opioids, muscle relaxants, antidepressants, anticonvulsants, muscle relaxants, and others have only temporary efficacy in general, with concerns for side effects related to long-term use. CLBPcurrent market size is entirely dependent on supportive treatment regimens, along with the drugs that have been approved to treat comorbidities associated with CLBP. • DelveInsight © 2019 | All rights reserved

  4. CLBP Emerging Drugs & Companies 01 Drug- Tanezumab Company- Pfizer 02 Drug- Fasinumab Company- Teva pharmaceutical 03 Drug- NKTR-181 Company- Nektar Pharmaceuticals 04 Drug- GRT6005 Company- Grünenthal GmbH • DelveInsight © 2019 | All rights reserved

  5. Complete Information For complete information on Chronic Lower Back Pain Market Insights, Epidemiology & Market Forecast-2028 please click the link below CLICK HERE OR Write Us At  info@delveinsight.com • DelveInsight © 2019 | All rights reserved

  6. About DelveInsight Mission 2 1 3 About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2019 | All rights reserved

  7. Services by DelveInsight PharmDelve Forecasting OpportunityAssessment Consulting ReportStore MarketIntelligence Competitive Analysis Pipeline • DelveInsight © 2019 | All rights reserved

  8. Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2019 | All rights reserved

  9. Pompe Disease 9

More Related